Aclarion (ACON) Stock: Buy, Sell, or Hold?
ACON - Aclarion, Inc. Common Stock
$1.94
-0.20 (-9.35%)
βΌ
5d:
-17.45%
30d:
-25.95%
90d:
-26.52%
WAIT
LOW Confidence
Analysis Updated: Oct 14, 2026 12:00 AM ET
Earnings: Nov 11, 2026
26d
Get Alerted When ACON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: ACON is down 17.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: ACON is down 17.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ACON is currently trading at $1.94, which is considered oversold relative to its 30-day fair value range of $2.26 to $2.64.
Technical Outlook: Technically, ACON is in a strong downtrend. The price is currently testing key support at $1.89. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.3% recently.
Market Sentiment: ACON scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.62 (+293.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACON is in a strong downtrend. The price is currently testing key support at $1.89. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.3% recently.
Market Sentiment: ACON scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.62 (+293.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.26 -
$2.64
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.3%)
- BULLISH: Trading 293.0% below Wall St target ($7.62)
- WARNING: Composite score 42/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.26 -
$2.64
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.89
Resistance Level
$2.50
Current Trend
Strong Downtrend
Technical data as of
Oct 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.35
Wall Street Target
$7.63
(+293.0%)
Revenue Growth (YoY)
30.5%
Share & Embed Analysis
Last updated: October 15, 2026 8:07 AM ET
Data refreshes hourly during market hours. Next update: 9:07 AM
Data refreshes hourly during market hours. Next update: 9:07 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$295 | 37 SELL |
|
WAY
Waystar Holding Corp. Co⦠|
STRONG BUY
23 analysts |
$34 | 36 SELL |
|
PRVA
Privia Health Group Inc |
STRONG BUY
18 analysts |
$31 | 48 HOLD |
|
GEHC
GE HealthCare Technologi⦠|
STRONG BUY
21 analysts |
$90 | 46 HOLD |
|
BTSG
BrightSpring Health Serv⦠|
STRONG BUY
18 analysts |
$79 | 35 SELL |